Fluence Newsletter - November 2021
Fluence’s winter courses, funding announcement, and new staff!
We have some exciting news to share with you from Fluence! Yesterday, we announced that Fluence has begun raising funds to scale Fluence’s expert-driven training platform by expanding our e-learning capabilities, starting with a $1.6 million first close lead investment from JLS Fund, Palo Santo, and Neo Kuma Ventures. Read more in our press release.
“Bringing our expertise from multiple psychedelic therapy clinical trials and research leadership positions, our team delivers meaningful, engaging, and impactful training experiences to individual therapists and entire research teams,” said Fluence co-founder Elizabeth Nielson, Ph.D. “We look forward to implementing the expansion that this funding will allow and welcoming the next generation of therapists to our field.”
Fluence’s winter sessions are officially available for registration and packed with important information and interactive activities. Over the last month, we have been busy welcoming new staff, teaching our Fall courses, and holding our Experiential Training retreat.
From October 19-24, we held our Experiential Training Retreat at Menla in the Catskills, where 24 participants gathered for a dynamic week of meditation, movement, and community building to enhance their current or future practice in psychedelic therapy and integration therapy.
Meetings for the Postgraduate Certificate in Ketamine-Assisted Psychotherapy start on November 19, so apply now!
Be sure to explore our many upcoming trainings and courses, led by the world’s leading experts on psychedelic therapy and psychedelic integration.
As always, stay connected with Fluence by following us on LinkedIn, Facebook, Twitter, and Instagram.
Until next time,
Register for Psychedelic Integration: Premise and Promise
Join us January 21-23, 2022 for our upcoming live online course, “Psychedelic Integration: Premise and Promise.” This is your opportunity to gain greater insights into how to work with patients with a history of psychedelic use or who have expressed interest in using psychedelics.
This interactive training will include experiential learning, demonstrations, self-reflection, and role-play exercises. The themes of spirituality, ethics, and critical discussion will be woven throughout the program with opportunities for connection, collaboration, and building community.
Register for Understanding Ketamine Live/Online Course
While ketamine is a powerful and promising treatment, effective and safe treatment involves far more than administering the drug itself. This course will teach medical professionals and mental health care providers how they can help their patients safely and legally access ketamine treatment, as well as prepare for and integrate those treatments using a psychedelic-assisted therapy framework. This is a weekend course taking place from December 11-12, 2021, from 10:00 AM-5:00 PM EST.
Winter Course: Psychedelics and Psychoanalysis
This 12-week course uses contemporary and historical sources to teach the numerous ways psychoanalysis and psychedelics have been, and are, involved with one another. We hope, also, to sketch out a roadmap deepening this important affiliation. This course is for more advanced students who possess basic clinical and theoretical knowledge of psychoanalysis, as well as having basic information regarding psychedelic therapy.
Led by Dr. Jeffrey Guss, this course starts January 26, 2022.
Winter Course—Psychological Approaches to Psychedelic Therapy—Now Open for Registration
Starting on February 2, 2022, Psychological Approaches to Psychedelic Therapy focuses on various psychological concepts that are critical for psychedelic therapy.
The goal of this reading and study group is to analyze and understand the ways in which psychedelic therapy helps individuals through a variety of indications. Throughout the course, participants will be asked to compare, critique, and explore new ways that psychedelic therapy can be used.
If you’re interested in joining this course, apply here to secure your spot for the 12-week program which will provide more information about the methods of research.
Apply for the Psychedelic Integration Clinical Consultation Group
Join Fluence Assistant Trainer Rebecca Kronman, LCSW for her Psychedelic Integration Clinical Consultation Group that allows participants to present case material from their own practices.
The goal of this group is to provide a safe, informative, and confidential place for therapists and other practitioners to discuss their clinical work in psychedelic integration. Being able to discuss clinical work, expanded psychedelic knowledge, helping others expand their work and understandings.
This 12-week course starts on January 10, 2022, so be sure to secure a spot.
Apply for Integration Essentials
This 14-week reading and study group is aimed at deepening your understanding of psychedelic therapy through weekly topics, such as harm reduction and psychedelic integration therapy, ego dissolution, and the six unifying theories of psychedelic effects.
Be sure to register for one of our two online winter sections.
Ketamine-Assisted Psychotherapy Certificate Program Open House
To learn more about Fluence’s Postgraduate Certificate in Ketamine-Assisted Psychotherapy, we invite you to attend a free one-hour Open House meeting this November 12. Led by Fluence co-founder Dr. Elizabeth Nielson and our new Interim KAP Certificate Program Director, Donna Sorgen, LMHC, LPC, we’ll provide an overview of the program and hold a live Q&A discussion. The Open Houses will take place on November 12 (3-4 pm EDT).
Meet our new Lead Trainer,
Dr. Lawrence Fischman
Lawrence Fischman, MD, is a psychiatrist and psychoanalyst, who is joining Fluence to teach Psychoanalytic Explorations alongside Dr. Jeffrey Guss. Dr. Fischman has practiced in New York and Maine for 36 years. In addition to his full-time private practice in New York, he was a Clinical Instructor in Psychiatry at New York-Presbyterian/Weill Cornell Medical Center. In 1996, he moved to Maine, and became a Clinical Instructor in Psychiatry at Tufts University School of Medicine Maine Track, where he also serves on the Admissions subcommittee. In 1983, he published a paper comparing psychedelic drug states with dreams and psychosis in Schizophrenia Bulletin. In 2019, inspired by the renaissance in psychedelic research, he published a paper in Neuropsychoanalysis on psychedelic-assisted psychotherapy. He has enjoyed living, working and raising a family in Maine, and is excited by the emerging possibilities for integrating psychedelic experiences with psychoanalytically-based psychotherapy.
Welcome to our new Assistant Trainer,
Haya Al-Hejailan, MSc
Haya Al-Hejailan, MSc, is a wellbeing coach, positive psychology practitioner and psychedelic integrationist. She holds a B.A. in psychology from Claremont McKenna College where she focused her senior thesis on the clinical uses of psychedelics. She recently received an MSc in applied positive psychology and coaching psychology from the University of East London, with a dissertation research project exploring the impact of psychedelic use on wellbeing in light of the COVID-19 pandemic. Haya is co-directing and co-producing The Psychedelic Renaissance Documentary and works as an events planner for The Psychedelic Society UK. She has previously worked as an administrator with Synthesis retreats and was involved with the French psychedelic society. Haya intends to dedicate her career in the field to help bridge the gap between psychedelic science and cultures in the SWANA/MENA region (South West Asia and North Africa/Middle East and North Africa).
Ketamine-assisted psychotherapy for trauma-exposed patients in an outpatient setting
Fluence Lead Trainer Dr. Alan Davis recently published a paper in AK Journals on “Ketamine-assisted psychotherapy for trauma-exposed patients in an outpatient setting.”
It’s the first study to assess the effectiveness of ketamine-assisted psychotherapy, as opposed to just ketamine, for the treatment of PTSD.